Preparation of gelatin hydrogels incorporating low-molecular-weight heparin for anti-fibrotic therapy

Acta Biomaterialia

Volumn 8, Issue 2, 2012, Pages 646-652

  Saito, Takashi ^a   Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Anti fibrotic therapy; Controlled release; Gelatin hydrogel; LMWH

Indexed keywords

BIOACTIVITY; CROSSLINKING; ETHYLENE; MOLECULAR WEIGHT; POLYSACCHARIDES; SOLUTIONS;

ANTI-FIBROTIC THERAPY; CATIONIZED; CONDITION; CONTROLLED RELEASE; CROSS LINKING; GELATIN HYDROGELS; HYDROGEL DEGRADATION; LOW-MOLECULAR WEIGHT HEPARINS; PHOSPHATE BUFFERED SALINE SOLUTIONS; TIME-PERIODS;

HYDROGELS;

ANTIFIBROTIC AGENT; CATION; COLLAGENASE; ETHYLENEDIAMINE; GELATIN; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHATE BUFFERED SALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED DRUG RELEASE; CROSS LINKING; DRUG ACTIVITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; FIBROSIS; HYDROGEL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84855418347     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2011.10.025     Document Type: Article

References (43)

1. D. Costa, M.G. Miguel, and B. Lindman Swelling properties of cross-linked DNA gels Adv Colloid Interface Sci 158 2010 21
2. A.J. Halliday, and M.J. Cook Polymer-based drug delivery devices for neurological disorders CNS Neurol Disord Drug Targets 8 2009 205
3. R.C. Mundargi, V.R. Babu, V. Rangaswamy, P. Patel, and T.M. Aminabhavi Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives J Control Release 125 2008 193
4. E.A. Simone, T.D. Dziubla, and V.R. Muzykantov Polymeric carriers: role of geometry in drug delivery Expert Opin Drug Deliv 5 2008 1283
5. W.J. Habraken, J.G. Wolke, and J.A. Jansen Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering Adv Drug Deliv Rev 59 2007 234
6. M. Prabaharan Review paper: chitosan derivatives as promising materials for controlled drug delivery J Biomater Appl 23 2008 5
7. C. Kojima Design of stimuli-responsive dendrimers Expert Opin Drug Deliv 7 2010 307
8. S. Ganta, H. Devalapally, A. Shahiwala, and M. Amiji A review of stimuli-responsive nanocarriers for drug and gene delivery J Control Release 126 2008 187
9. S.W. Kim, Y.H. Bae, and T. Okano Hydrogels: swelling, drug loading, and release Pharm Res 9 1992 283
10. M. Amon, R. Menapace, U. Radax, and H. Freyler In vivo study of cell reactions on poly(methyl methacrylate) intraocular lenses with different surface properties J Cataract Refract Surg 22 Suppl. 1 1996 825
11. P.S. Stayton, M.E. El-Sayed, N. Murthy, V. Bulmus, C. Lackey, and C. Cheung 'Smart' delivery systems for biomolecular therapeutics Orthod Craniofac Res 8 2005 219
12. Y. Tabata, A. Nagano, and Y. Ikada Biodegradation of hydrogel carrier incorporating fibroblast growth factor Tissue Eng 5 1999 127
13. Y. Tabata Tissue regeneration based on growth factor release Tissue Eng 9 Suppl. 1 2003 S5
14. M. Yamamoto, and Y. Tabata Tissue engineering by modulated gene delivery Adv Drug Deliv Rev 58 2006 535
15. T. Kushibiki, R. Tomoshige, K. Iwanaga, M. Kakemi, and Y. Tabata Controlled release of plasmid DNA from hydrogels prepared from gelatin cationized by different amine compounds J Control Release 112 2006 249
16. G. Matsumoto, T. Kushibiki, Y. Kinoshita, U. Lee, Y. Omi, and E. Kubota Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma Cancer Sci 97 2006 313
17. H. Kohara, S. Tajima, M. Yamamoto, and Y. Tabata Angiogenesis induced by controlled release of neuropeptide substance P Biomaterials 31 2010 8617
18. T. Tanigo, R. Takaoka, and Y. Tabata Sustained release of water-insoluble simvastatin from biodegradable hydrogel augments bone regeneration J Control Release 143 2010 201
19. Y. Uesugi, H. Kawata, J. Jo, Y. Saito, and Y. Tabata An ultrasound-responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy J Control Release 147 2010 269
20. Y. Tabata, M. Miyao, T. Inamoto, T. Ishii, Y. Hirano, and Y. Yamaoki De novo formation of adipose tissue by controlled release of basic fibroblast growth factor Tissue Eng 6 2000 279
21. J. Esaki, A. Marui, Y. Tabata, and M. Komeda Controlled release systems of angiogenic growth factors for cardiovascular diseases Expert Opin Drug Deliv 4 2007 635
22. T. Kushibiki, and Y. Tabata A new gene delivery system based on controlled release technology Curr Drug Deliv 1 2004 153
23. H. Nakajima, Y. Sakakibara, K. Tambara, A. Iwakura, K. Doi, and A. Marui Therapeutic angiogenesis by the controlled release of basic fibroblast growth factor for ischemic limb and heart injury: toward safety and minimal invasiveness J Artif Organs 7 2004 58
24. K. Matsumoto, H. Tajima, H. Okazaki, and T. Nakamura Heparin as an inducer of hepatocyte growth factor J Biochem 114 1993 820
25. W. Abe, K. Ikejima, T. Lang, K. Okumura, N. Enomoto, and T. Kitamura Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat J Hepatol 46 2007 286
26. I.M. Pecly, R.G. Goncalves, E.P. Rangel, C.M. Takiya, F.S. Taboada, and C.A. Martinusso Effects of low molecular weight heparin in obstructed kidneys: decrease of collagen, fibronectin and TGF-beta, and increase of chondroitin/dermatan sulfate proteoglycans and macrophage infiltration Nephrol Dial Transplant 21 2006 1212
27. A.G. Turpie, A.S. Gallus, and J.A. Hoek A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement N Engl J Med 344 2001 619
28. E. Gray, B. Mulloy, and T.W. Barrowcliffe Heparin and low-molecular-weight heparin Thromb Haemost 99 2008 807
29. R. Sakiyama, K. Fukuta, K. Matsumoto, M. Furukawa, Y. Takahashi, and T. Nakamura Stimulation of hepatocyte growth factor production by heparin-derived oligosaccharides J Biochem 141 2007 653
30. S.L. Snyder, and P.Z. Sobocinski An improved 2,4,6- trinitrobenzenesulfonic acid method for the determination of amines Anal Biochem 64 1975 284
31. J.G. de Jong, R.A. Wevers, C. Laarakkers, and B.J. Poorthuis Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses Clin Chem 35 1989 1472
32. Y. Yoshio, M. Miyazaki, K. Abe, T. Nishino, A. Furusu, and Y. Mizuta TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model Kidney Int 66 2004 1677
33. D.M. Morgan, V.L. Larvin, and J.D. Pearson Biochemical characterisation of polycation-induced cytotoxicity to human vascular endothelial cells J Cell Sci 94 Pt. 3 1989 553
34. Y. Kimura, T. Inamoto, and Y. Tabata Adipose tissue formation in collagen scaffolds with different biodegradabilities J Biomater Sci Polym Ed 21 2010 463
35. T. Ogawa, T. Akazawa, and Y. Tabata In vitro proliferation and chondrogenic differentiation of rat bone marrow stem cells cultured with gelatin hydrogel microspheres for TGF-beta1 release J Biomater Sci Polym Ed 21 2010 609
36. Y. Kimura, N. Miyazaki, N. Hayashi, S. Otsuru, K. Tamai, and Y. Kaneda Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue Tissue Eng Part A 16 2010 1263
37. T. Ohno, S. Hirano, S. Kanemaru, M. Yamashita, H. Umeda, and A. Suehiro Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model Ann Otol Rhinol Laryngol 116 2007 762
38. R.A. Panganiban, and R.M. Day Hepatocyte growth factor in lung repair and pulmonary fibrosis Acta Pharmacol Sin 32 2011 12
39. S. Schievenbusch, I. Strack, M. Scheffler, K. Wennhold, J. Maurer, and R. Nischt Profiling of anti-fibrotic signaling by hepatocyte growth factor in renal fibroblasts Biochem Biophys Res Commun 385 2009 55
40. S. Mizuno, K. Matsumoto, and T. Nakamura HGF as a renotrophic and anti-fibrotic regulator in chronic renal disease Front Biosci 13 2008 7072
41. M. Jinnin, H. Ihn, Y. Mimura, Y. Asano, K. Yamane, and K. Tamaki Effects of hepatocyte growth factor on the expression of type I collagen and matrix metalloproteinase-1 in normal and scleroderma dermal fibroblasts J Invest Dermatol 124 2005 324
42. M.H. Branton, and J.B. Kopp TGF-beta and fibrosis Microbes Infect 1 1999 1349
43. J. Yang, C. Dai, and Y. Liu Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction Am J Pathol 163 2003 621